Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 109
Filter
1.
J Intern Med ; 265(3): 359-72, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19019193

ABSTRACT

OBJECTIVES: The objective was the identification and functional characterization of mutations in the ABCA1 gene in four patients with severe HDL deficiency. SUBJECTS: Patients were referred to the clinic because of almost complete HDL deficiency. METHODS: The ABCA1 gene was sequenced directly. The analysis of the ABCA1 protein, ABCA1 mRNA and ABCA1-mediated cholesterol efflux was performed in cultured fibroblasts. Intracellular localization of ABCA1 mutants was investigated in transfected HEK293 cells. RESULTS: Two patients were homozygous for mutations in the coding region of the ABCA1 gene, resulting in an amino acid substitution (p.A1046D) and a truncated protein (p.I74YFsX76). The third patient was homozygous for a splice site mutation in intron 35 (c.4773 + 1g>a), resulting in an in-frame deletion of 25 amino acids (del p.D1567_K1591) in ABCA1. These patients had clinical manifestations of accumulation of cholesterol in the reticulo-endothelial system. The fourth patient, with preclinical atherosclerosis, was a compound heterozygote for two missense mutations (p.R587W/p.W1699C). ABCA1-mediated cholesterol efflux was abolished in fibroblasts from patients with p.A1046D and del p.D1567_K1591 mutants and in fibroblasts homozygous for p.R587W. A reduced ABCA1 protein content was observed in these cells, suggesting an increased intracellular degradation. The mutant p.W1699C was largely retained in the endoplasmic reticulum, when expressed in HEK293 cells. CONCLUSIONS: The homozygotes for mutations which abolish ABCA1 function showed overt signs of involvement of the reticulo-endothelial system. This was not the case in the compound heterozygote for missense mutations, suggesting that this patient retains some residual ABCA1 function that reduces cholesterol accumulation in the reticulo-endothelial system.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Cholesterol/metabolism , Lipoproteins, HDL/deficiency , Mutation, Missense/genetics , ATP Binding Cassette Transporter 1 , Adult , Aged , Amino Acid Substitution , Apolipoprotein A-I/genetics , Child , Child, Preschool , DNA Mutational Analysis , Exons/genetics , Female , Fibroblasts/metabolism , Frameshift Mutation , Humans , Male , Middle Aged
3.
Nutr Metab Cardiovasc Dis ; 13(4): 202-10, 2003 Aug.
Article in English | MEDLINE | ID: mdl-14650352

ABSTRACT

BACKGROUND AND AIM: Several genetic polymorphisms have been found to be involved in cardiovascular risk, and many studies have documented the beneficial effect of systematic physical activity (PA) on the cardiovascular system. Our aim was to investigate the interactive effects of PA and genetic background on plasma lipids and homocysteine (tHcy) levels. METHODS AND RESULTS: Clinical and metabolic parameters, dietary intakes and some polymorphisms of the genes involved in cardiovascular risk (Apo E, fatty acid binding protein-2, Apo AII, hepatic lipase and methylene tetrahydrofolate reductase) were determined in 100 men aged over 40 years who cycle 120-150 Km/week and 100 age-matched sedentary controls. The physically active subjects had lower concentrations of plasma LDL cholesterol (LDL-C), triglyceride (TG), Apo B, glucose and tHcy, and higher concentrations of plasma HDL cholesterol (HDL-C) and Apo AI than the sedentary men; they also had larger LDL particle sizes (LDLs). The LDL-C and Apo B raising effect of the Apo E epsilon 4 allele detectable in the sedentary subjects was totally absent in the cyclists, in whom the LDL-C and Apo B lowering effect of the epsilon 2 allele was observed. PA blunted the TG-raising effect of the Apo AII-265TT genotype, and amplified the HDL-C raising effect of the HL-250AA genotype. PA had a small but significant lowering effect on plasma tHcy adjusted for folate levels in subjects with the 677TT genotype of the MTHFR gene. CONCLUSIONS: Extended high-intensity PA in men aged over 40 years may modify their metabolic cardiovascular risk factors even in the presence of some unfavourable genotypes.


Subject(s)
Apolipoproteins/genetics , Cardiovascular Diseases/genetics , Cardiovascular Diseases/prevention & control , Homocysteine/blood , Motor Activity , Adult , Blood Glucose/metabolism , Case-Control Studies , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , DNA Primers , Diet Records , Humans , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Genetic , Triglycerides/blood
4.
Electrophoresis ; 22(18): 4012-5, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11700734

ABSTRACT

This study evaluated the applicability of microchip electrophoresis to the sizing of microsatellites suitable to genetic, clinical and forensic applications. The evaluation was performed with the D19S394 tetranucleotide (AAAG) repeat characterized by a wide variation in the repeat number (1-17) and a short recombination distance from the low-density lipoprotein (LDL)-receptor gene that makes it suitable to cosegregation analysis of familial hypercholesterolemia (FH). The study was performed with 70 carriers of two LDL-receptor mutations common in northern Italy (i.e., the 4 bp insertion in exon 10 known as FH-Savona and the D200G missense mutation in the exon 4, known as FH-Padova 1) and 100 healthy controls. The polymerase chain reaction (PCR) amplification products prepared with a cosolvent PCR protocol and an antibody-protected polymerase were directly analyzed with an apparatus for high-voltage capillary electrophoresis on microchips and laser-induced fluorescence detection equipped with chips for the analysis of 25-500 bp dsDNA fragments. The test could not be extended to dinucleotide repeats due to the resolution characteristics of the available microchip. This novel approach was able to distinguish 17 microsatellite alleles varying from 0 to 17 repeats. Many of these alleles were quite rare, but the seven more abundant accounted for over the 70% of allele distribution in control population. The standard deviation in the sizing of the most abundant alleles ranged from +0.60 to +/- 0.75 bp. This indicated that the size attribution to a conventional allele using the +/- 1 bp range around it allowed a confidence limit above the 80 %. The sizing of D19S394 obtained this way allowed the cosegregation analysis with both the FH mutations tested. Therefore, this innovative approach to microsatellite sizing was much simpler, but equally effective as traditional capillary electrophoresis, at least with tetranucleotide repeats.


Subject(s)
Electrophoresis, Capillary/methods , Hyperlipoproteinemia Type II/genetics , Microchemistry/methods , Microsatellite Repeats , Receptors, LDL/genetics , Alleles , DNA/blood , DNA/genetics , Electrophoresis, Capillary/instrumentation , Exons/genetics , Genetic Predisposition to Disease , Heterozygote , Humans , Hyperlipoproteinemia Type II/epidemiology , Italy/epidemiology , Leukocytes/chemistry , Microchemistry/instrumentation , Mutagenesis, Insertional , Mutation, Missense , Point Mutation , Polymerase Chain Reaction , Reproducibility of Results
5.
Exp Biol Med (Maywood) ; 226(2): 112-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11446434

ABSTRACT

In order to test the effects of estrogen on the clearance of cholesterol of dietary origin from the blood and its elimination from the body via the bile in an in vivo animal model, the fate of radioactivity from intravenously injected [3H]cholesterol-labeled chylomicrons was investigated in the rat. The labeled lipoproteins were administered intrajugularly to male rats previously given 17alpha ethinyl estradiol or the vehicle only, and the removal of the radioactivity from the blood and its uptake by the liver and secretion into bile was determined. Experiments were carried out in animals with or without prior drainage (20 hr) of the pool of bile acids in the enterohepatic circulation, to take account of the different demands of the liver for cholesterol in the two conditions. In rats without biliary drainage, estrogen treatment decreased the rate of removal of radioactivity from the blood by about 30% and the recovery of cholesterol in the liver by about 50% in the first 30 min after injection of the labeled chylomicrons. After biliary drainage, however, the recovery of label in the liver after 90 min was similar in estrogen-treated and control animals, although its secretion into bile was markedly reduced in the estrogen-treated group (total biliary secretion in 90 min was 26% of the value found in control rats). In addition, the apolipoprotein E (aopE) content of the serum total lipoproteins was markedly reduced by estrogen. These results provide direct evidence indicating that estrogen retards the elimination of dietary cholesterol from the body via the bile in the rat, and this is likely to be mainly due to a reduced level of apoE in chylomicrons. In view of this, we suggest that the hypothesis that estrogen increases the hepatic uptake of chylomicron cholesterol, and its excretion in the bile during contraceptive and hormone replacement therapy should be re-examined.


Subject(s)
Cholesterol, Dietary/metabolism , Cholesterol/metabolism , Chylomicrons/metabolism , Estrogens/pharmacology , Ethinyl Estradiol/pharmacology , Animals , Bile/metabolism , Fish Oils/metabolism , Male , Postprandial Period/physiology , Rats
6.
Exp Biol Med (Maywood) ; 226(3): 191-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11361037

ABSTRACT

The absorption, remodeling, and delivery of dietary lipids by intestinal cells are part of a complex multi-step process, the dynamics of which is influenced by the lipid composition of the diet and the physiological state of enterocytes. Emerging data indicate that, among the parameters known to modulate the cell functionality, the internal oxidative balance plays a pivotal role. In this study, we analyzed the effects of varying redox equilibria on the way in which the intestinal Caco-2 cell line utilize an exogenous lipid source such as oleic acid. Firstly, we manipulated the intracellular levels of soluble thiols (glutathione), and the amount of cell-associated products of lipid peroxidation, commonly regarded as two critical parameters characterizing the redox profile of the cells. Two different perturbants having opposite effects on the cell's redox profile were used: the pro-oxidizing agent CuSO4 (2.5 and 10 microM) and the antioxidant and thiol supplier N-acetylcysteine (NAC, 2.5 and 5 mM). The influence of these mild but critical manipulations on the incorporation of oleate (50 and 500 microM) into cholesterol, triacylglycerol, and phospholipid was then evaluated. We found that the emerging pro-oxidant condition induced by CuSO4 pre-exposure was associated with a significant up-regulation of phospholipid synthesis, while minor modifications were detected in that of triacylglycerols. Conversely, when a more reducing state was induced by NAC pre-treatment, there was a significant down-regulation of triacylglycerol synthesis, with minor modifications in that of phospholipids. In addition, the incorporation of oleic acid in the cholesteryl ester fraction appeared to be unmodified under all the redox conditions reported. On the whole, these results indicate that the pre-existing internal redox potential of the enterocytes is a critical factor that is able to differentially modulate lipid synthesis at the intestinal level. Thus, the adoption of a strategy designed to control/buffer the antioxidant capacity of the gastrointestinal tract could have important consequences for the modulation of lipid balance in the body.


Subject(s)
Intestinal Mucosa/metabolism , Lipids/biosynthesis , Oleic Acids/metabolism , Acetylcysteine/pharmacology , Aldehydes/metabolism , Antioxidants/pharmacology , Caco-2 Cells , Copper Sulfate/pharmacology , Glutathione/metabolism , Glutathione Disulfide/metabolism , Humans , Malondialdehyde/metabolism , Oxidants/pharmacology , Oxidation-Reduction
7.
Atherosclerosis ; 154(3): 599-605, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11257260

ABSTRACT

The proband is a 50 year-old woman born from a consanguineous marriage. She has been suffering from angina pectoris since the age of 38 and underwent coronary bypass surgery for three-vessel disease at 48. The presence of low plasma levels of total cholesterol and high density lipoprotein (HDL) cholesterol (2.4 and 0.1 mmol/l) and apo AI (<15 mg/dl), associated with corneal lesions and a mild splenomegaly suggested the diagnosis of Tangier disease. However, none of the other features of Tangier disease, including hepatomegaly, anemia and peripheral neuropathy, were present. The analysis of the dinucleotide microsatellites located in chromosome 9q31 region demonstrated that the proband was homozygous for the alleles of D9S53, D9S1784 and D9S1832. The mother and son of the proband, both with low levels of HDL cholesterol, shared one of the proband's haplotypes, whereas neither of these haplotypes was present in the normolipidemic proband's sister. The sequence of ATP-binding cassette transporter 1 (ABC1-1) cDNA obtained by reverse transcription-PCR (RT-PCR) of total RNA isolated from cultured fibroblasts showed that the proband was homozygous for a C>T transition in exon 13, which caused a tryptophane for arginine substitution (R527W). This mutation was confirmed by direct sequencing of exon 13 amplified from genomic DNA. It can be easily screened, as the nucleotide change introduces a restriction site for the enzyme Afl III. R527W substitution occurs in a highly conserved region of the NH2 cytoplasmic domain of ABC1 protein. R527W co-segregates with the low HDL phenotype in the family and was not found in 200 chromosomes from normolipidemic individuals.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Coronary Disease/genetics , Glycoproteins/genetics , Point Mutation , Tangier Disease/genetics , ATP Binding Cassette Transporter 1 , Amino Acid Sequence/genetics , Base Sequence/genetics , Chromosomes, Human, Pair 9/genetics , Coronary Disease/physiopathology , Female , Genetic Testing , Genotype , Humans , Middle Aged , Molecular Sequence Data , Mutation/genetics , Pedigree , Phenotype , Polymorphism, Genetic , Severity of Illness Index
8.
Clin Sci (Lond) ; 100(2): 191-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11171288

ABSTRACT

Several studies have suggested that the oxidative modification of low-density lipoprotein (LDL) could play a key role in the early stages of atherosclerosis. The susceptibility of LDL to oxidation has been found to be greater in patients with coronary heart disease. Familial hypercholesterolaemia (FH) is a powerful clinical model in which to study the predictive role of LDL in atherogenesis. LDL-apheresis is a treatment that is able to decrease lipid levels in plasma. This study was aimed at investigating the reducing capacity of erythrocytes and the in vitro susceptibility to oxidation of LDL isolated from patients with homozygous, heterozygous and double-heterozygous FH, who were treated fortnightly with LDL-apheresis or left untreated. In 14 FH patients, at baseline and after a cycle of treatment, the susceptibility of LDL to oxidative modification was analysed by studying the kinetics of conjugate diene formation. Plasma hydroperoxides, polyunsaturated fatty acid content, LDL electrophoretic mobility on agarose, the titre of auto-antibodies against oxidized LDL and serum paraoxonase activity were also measured. Furthermore, in order to evaluate a potential relationship between LDL oxidation and redox status, erythrocyte GSH and ATP levels were determined in FH patients treated regularly or never treated previously by LDL-apheresis. Unlike in the control group, the oxidative status of LDL in all FH patients was modified by LDL-apheresis, as revealed by the higher negative charge and the increase in levels of hydroperoxides and antibodies against oxidized LDL in the plasma. Our findings suggest both an acute effect and a long-term effect of LDL-apheresis in FH patients treated with dextran sulphate cellulose apheresis. The acute effect of LDL-apheresis on the susceptibility to oxidation of plasma and LDL was demonstrated by significant decreases in plasma hydroperoxide content, total LDL concentration and polyunsaturated fatty acid content. The increased resistance of LDL to oxidation was shown by prolongation of the lag time (P<0.05) in samples after a single cycle of treatment. The long-term effect of LDL-apheresis was demonstrated by the comparable values for lag phases (obtained from the kinetics of conjugate diene formation) in patients under active treatment and controls. Compared with healthy controls and untreated patients, the erythrocyte GSH content was significantly higher (P

Subject(s)
Erythrocytes/physiology , Hyperlipoproteinemia Type II/therapy , Lipoproteins, LDL/blood , Plasmapheresis , Adenosine Triphosphate/blood , Adolescent , Adult , Child , Child, Preschool , Electrophoresis, Agar Gel , Erythrocytes/metabolism , Fatty Acids, Unsaturated/blood , Female , Glutathione/blood , Humans , Hyperlipoproteinemia Type II/blood , Lipid Peroxides/blood , Lipoproteins, LDL/physiology , Male , Middle Aged , Oxidation-Reduction
9.
Arterioscler Thromb Vasc Biol ; 20(9): E41-52, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10978268

ABSTRACT

Seventy-one mutations of the low density lipoprotein (LDL) receptor gene were identified in 282 unrelated Italian familial hypercholesterolemia (FH) heterozygotes. By extending genotype analysis to families of the index cases, we identified 12 mutation clusters and localized them in specific areas of Italy. To evaluate the impact of these mutations on the clinical expression of FH, the clusters were separated into 2 groups: receptor-defective and receptor-negative, according to the LDL receptor defect caused by each mutation. These 2 groups were comparable in terms of the patients' age, sex distribution, body mass index, arterial hypertension, and smoking status. In receptor-negative subjects, LDL cholesterol was higher (+18%) and high density lipoprotein cholesterol lower (-5%) than the values found in receptor-defective subjects. The prevalence of tendon xanthomas and coronary artery disease (CAD) was 2-fold higher in receptor-negative subjects. In patients >30 years of age in both groups, the presence of CAD was related to age, arterial hypertension, previous smoking, and LDL cholesterol level. Independent contributors to CAD in the receptor-defective subjects were male sex, arterial hypertension, and LDL cholesterol level; in the receptor-negative subjects, the first 2 variables were strong predictors of CAD, whereas the LDL cholesterol level had a lower impact than in receptor-defective subjects. Overall, in receptor-negative subjects, the risk of CAD was 2.6-fold that of receptor-defective subjects. Wide interindividual variability in LDL cholesterol levels was found in each cluster. Apolipoprotein E genotype analysis showed a lowering effect of the epsilon2 allele and a raising effect of the epsilon4 allele on the LDL cholesterol level in both groups; however, the apolipoprotein E genotype accounted for only 4% of the variation in LDL cholesterol. Haplotype analysis showed that all families of the major clusters shared the same intragenic haplotype cosegregating with the mutation, thus suggesting the presence of common ancestors.


Subject(s)
Hyperlipoproteinemia Type II/genetics , Receptors, LDL/genetics , Adult , Cholesterol, LDL/metabolism , Coronary Disease/epidemiology , Coronary Disease/genetics , Coronary Disease/metabolism , Female , Genetic Variation , Haplotypes , Humans , Hyperlipoproteinemia Type II/epidemiology , Hyperlipoproteinemia Type II/metabolism , Italy , Male , Multigene Family , Mutation , Phenotype , Prevalence
10.
Gastroenterology ; 118(5): 912-20, 2000 May.
Article in English | MEDLINE | ID: mdl-10784590

ABSTRACT

BACKGROUND & AIMS: The role of the gallbladder in gallstone pathogenesis is still unclear. We examined the effects of gallbladder mucosal lipid absorption on lipid composition and cholesterol crystallization in bile. METHODS: The in vitro-isolated, intra-arterially perfused gallbladder model was used (1) to compare the absorption rates of lipids from standard bile by gallbladders obtained from 7 patients with cholesterol gallstones and 6 controls; and (2) to measure the microscopic cholesterol crystal detection time in cholesterol-enriched pig bile before and after lipid absorption by the pig gallbladder. RESULTS: Control gallbladders, but not cholesterol gallstone gallbladders, significantly reduced cholesterol (P < 0.02) and phospholipid (P < 0.01) and increased bile salt (P < 0.01) molar percentages in bile over a 5-hour period by efficient and selective cholesterol and phospholipid absorption. A histomorphometric study of the epithelial cells showed significantly higher values for nuclear density (P < 0.01) and nuclear (P < 0.05) and cytoplasmic (P < 0.05) areas in the cholesterol gallstone than the control group. Sequential microscopy of cholesterol-enriched pig bile showed significantly shorter cholesterol filament (P < 0.01) and typical cholesterol plate (P < 0. 02) detection times before than after exposure of bile to the gallbladder lipid absorption. CONCLUSIONS: In cholesterol gallstone disease, the human gallbladder epithelium loses its capacity to selectively and efficiently absorb cholesterol and phospholipids from bile, even if it is hyperplastic and hypertrophic. This epithelial dysfunction eliminates the positive effect that the normal gallbladder exerts on cholesterol solubility in bile and might be a pathogenetic cofactor for cholesterol gallstone formation.


Subject(s)
Bile/metabolism , Cholelithiasis/metabolism , Cholesterol/metabolism , Gallbladder/metabolism , Lipid Metabolism , Absorption , Animals , Bile/chemistry , Cholelithiasis/chemistry , Cholelithiasis/pathology , Cholesterol/chemistry , Epithelial Cells/pathology , Epithelial Cells/ultrastructure , Female , Gallbladder/pathology , Gallbladder/ultrastructure , Guinea Pigs , Humans , In Vitro Techniques , Male , Microscopy, Electron , Middle Aged , Mucous Membrane/metabolism , Phosphatidylcholines/metabolism
11.
Arterioscler Thromb Vasc Biol ; 20(1): 236-43, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10634824

ABSTRACT

One of the genetic features of the Sardinian population is the high prevalence of hemoglobin disorders. It has been estimated that 13% to 33% of Sardinians carry a mutant allele of the alpha-globin gene (alpha-thalassemia trait) and that 6% to 17% are beta-thalassemia carriers. In this population, a single mutation of beta-globin gene (Q39X, beta(0) 39) accounts for >95% of beta-thalassemia cases. Because previous studies have shown that Sardinian beta-thalassemia carriers have lower total and low density lipoprotein (LDL) cholesterol than noncarriers, we wondered whether this LDL-lowering effect of the beta-thalassemia trait was also present in subjects with familial hypercholesterolemia (FH). In a group of 63 Sardinian patients with the clinical diagnosis of FH, we identified 21 unrelated probands carrying 7 different mutations of the LDL receptor gene, 2 already known (313+1 g>a and C95R) and 5 not previously reported (D118N, C255W, A378T, T413R, and Fs572). The 313+1 g>a and Fs572 mutations were found in several families. In cluster Fs572, the plasma LDL cholesterol level was 5.76+/-1.08 mmol/L in subjects with beta(0)-thalassemia trait and 8.25+/-1.66 mmol/L in subjects without this trait (P<0.001). This LDL-lowering effect was confirmed in an FH heterozygote of the same cluster who had beta(0)-thalassemia major and whose LDL cholesterol level was below the 50th percentile of the distribution in the normal Sardinian population. The hypocholesterolemic effect of beta(0)-thalassemia trait emerged also when we pooled the data from all FH subjects with and without beta(0)-thalassemia trait, regardless of the type of mutation in the LDL receptor gene. The LDL-lowering effect of beta(0)-thalassemia may be related to (1) the mild erythroid hyperplasia, which would increase the LDL removal by the bone marrow, and (2) the chronic activation of the monocyte-macrophage system, causing an increased secretion of some cytokines (interleukin-1, interleukin-6, and tumor necrosis factor-alpha) known to affect the hepatic secretion and the receptor-mediated removal of apolipoprotein B-containing lipoproteins. The observation that our FH subjects with beta(0)-thalassemia trait (compared with noncarriers) have an increase of blood reticulocytes (40%) and plasma levels of interleukin-6 (+60%) supports these hypotheses. The lifelong LDL-lowering effect of beta(0)-thalassemia trait might slow the development and progression of coronary atherosclerosis in FH.


Subject(s)
Hyperlipoproteinemia Type II/complications , Hyperlipoproteinemia Type II/genetics , beta-Thalassemia/complications , beta-Thalassemia/genetics , Adolescent , Adult , Base Sequence , Cytokines/blood , DNA Primers/genetics , Female , Globins/genetics , Haplotypes , Heterozygote , Humans , Hyperlipoproteinemia Type II/blood , Italy , Lipoproteins, LDL/blood , Macrophage Activation , Male , Mutation , Phenotype , Receptors, LDL/genetics , beta-Thalassemia/blood
12.
Photochem Photobiol ; 71(1): 97-102, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10649896

ABSTRACT

Oxidized LDL (ox-LDL) have been involved in the pathogenesis of several human diseases including dermatological pathologies. Oxidative modification of low-density lipoproteins (LDL) is accompanied by both extensive degradation of its polyunsaturated fatty acids and production of lipoperoxides. These highly reactive products induce an intracellular oxidative stress with a variety of cytotoxic effects. In order to evaluate cellular damage induced by oxidative stress in epidermal cells, a human epidermoid carcinoma cell line in culture (A 431) was used as experimental model. Cell treatment with UV-oxidized LDL resulted in cytostatic and cytotoxic effects characterized by morphological and functional alterations: inhibition of cell proliferation, modifications of cytoskeleton network, microtubular derangement, loss of cell-cell and cell-substrate contacts, cell detachment and cell death by apoptosis. The ox-LDL-induced alterations were almost completely prevented by pre-incubating cells with alpha-tocopherol. The results presented here could be of relevance for a better comprehension of the pathogenic mechanisms of several human diseases, including dermatological pathologies, and could indicate that antioxidants such as alpha-tocopherol could represent an important therapeutic challenge in the maintenance of cell and tissue homeostasis in the long run.


Subject(s)
Lipoproteins, LDL/physiology , Vitamin E/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/ultrastructure , Humans , Lipoproteins, LDL/radiation effects , Microscopy, Electron, Scanning , Oxidative Stress , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , Tumor Cells, Cultured , Ultraviolet Rays
13.
Ann Ist Super Sanita ; 36(4): 459-64, 2000.
Article in English | MEDLINE | ID: mdl-11367925

ABSTRACT

The finding that the missense mutation C331W in the exon 7 of LDL-receptor gene, previously reported to occur in Holland and Belgium, caused the homozygote familial hypercholesterolemia (FH) in an individual from the district of Avellino induced us to search the mutation in a large area of region Campania. This was made with simple screening methods developed by ourselves and based on either the recognition of a primer-induced Fok I restriction site in the mutant allele or the PCR allele-specific amplification (PASA) of mutant allele. They were applied to a total of 144 unrelated cases recruited from where the mutation was more likely to occur. We failed to reveal any new case of C331W mutation that is indeed not common within the area of this screening, at spite of having been found in different countries.


Subject(s)
Point Mutation/genetics , Receptors, LDL/genetics , Adult , Child , Female , Humans , Italy , Male
14.
Redox Rep ; 4(3): 113-21, 1999.
Article in English | MEDLINE | ID: mdl-10496414

ABSTRACT

Olive oil contains several phenolic compounds with antioxidant activity, whose levels depend strongly on the kind of cultivar grown, fruit ripening effects and the oil extraction process. Therefore, the beneficial effects exerted by olive oil consumption on the resistance of low density lipoproteins (LDLs) to oxidation depend not only on an increased intake of mono-unsaturated fatty acids (e.g. oleate) which are less prone to oxidation, but also phenolic antioxidants. The aim of this study was to analyze in vitro effects exerted on the oxidative modification of Cu-stimulated human LDL by two olive oil biophenols, i.e. 3,4-dihydroxyphenylethanol-elenolic acid (3,4-DHPEA-EA) and protocatecuic acid. These compounds have not been investigated in as much detail as the better-known olive oil biophenols - such as tyrosol (p-HPEA), o-coumaric acid, vanillic acid, caffeic acid, oleuropein and 3,4-dihydroxyphenylethanol (3,4-DHPEA). Modification of LDL was tested by measuring the formation of intermediate and end products of lipid peroxidation such as conjugated dienes, lipid hydroperoxides, cholesterol and cholesteryl ester oxides, as well as studying the decrease in oxidizable substrates like polyunsaturated fatty acids. In addition, the increase in LDL negative charges was evaluated. The results demonstrate the two-tested olive oil biophenols show high antioxidant activities. In particular, protocatecuic acid and 3,4-DHPEA-EA show an antioxidant activity comparable with that of caffeic acid, oleuropein and 3,4-DHPEA. They are not only able to retard lipid peroxidation, but also to reduce the extent of its activity.


Subject(s)
Antioxidants/pharmacology , Hydroxybenzoates/pharmacology , Lipid Peroxides/analysis , Lipoproteins, LDL/blood , Phenols/pharmacology , Plant Oils/chemistry , Pyrans/pharmacology , Antioxidants/isolation & purification , Arachidonic Acid/analysis , Cholesterol/analysis , Fatty Acids/analysis , Humans , Hydroxybenzoates/isolation & purification , Linoleic Acid/analysis , Lipoproteins, LDL/drug effects , Lipoproteins, LDL/isolation & purification , Olive Oil , Phenols/isolation & purification , Plant Oils/pharmacology , Pyrans/isolation & purification
15.
J Nutr ; 129(7): 1269-77, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10395586

ABSTRACT

Experimental and clinical evidence suggest that oxidative stress causes cellular damage, leading to functional alterations of the tissue. Free radicals may thus play an important role in the pathogenesis of a number of human diseases. Among pro-oxidant agents, oxidized LDL lead to the production of cytotoxic reactive species, e.g., lipoperoxides, causing tissue injury and various subsequent pathologies including intestinal diseases. Thus, to analyze the oxidative damage induced by oxidized LDL to intestinal mucosa, we evaluated morphological and functional changes induced in the human colon adenocarcinoma cell line, Caco-2. In addition, we examined the protective effects exerted by tyrosol, 2-(4-hydroxyphenyl)ethanol, the major phenolic compound present in olive oil. Caco-2 cell treatment (24 and/or 48 h) with oxidized LDL (0.2 g/L) resulted in cytostatic and cytotoxic effects characterized by a series of morphological and functional alterations: membrane damage, modifications of cytoskeleton network, microtubular disorganization, loss of cell-cell and cell-substrate contacts, cell detachment and cell death. The oxidized LDL-induced alterations in Caco-2 cells were almost completely prevented by tyrosol which was added 2 h before and present during the treatments. Our results suggest that some biophenols, such as those contained in olive oil, may counteract the reactive oxygen metabolite-mediated cellular damage and related diseases, by improving in vivo antioxidant defenses.


Subject(s)
Antioxidants/pharmacology , Caco-2 Cells/drug effects , Intestinal Mucosa/drug effects , Lipoproteins, LDL/drug effects , Oxidative Stress/drug effects , Phenylethyl Alcohol/analogs & derivatives , Analysis of Variance , Antioxidants/therapeutic use , Caco-2 Cells/metabolism , Caco-2 Cells/ultrastructure , Humans , Intestinal Mucosa/metabolism , L-Lactate Dehydrogenase/metabolism , Oxidation-Reduction/drug effects , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Reactive Oxygen Species/metabolism
16.
Hum Mutat ; 13(5): 412, 1999.
Article in English | MEDLINE | ID: mdl-10338098

ABSTRACT

The LDL-receptor gene point mutation FH-Genoa/Palermo is the most frequent mutation responsible for Familial Hypercholesterolemia in Sicily. The mutation does not introduce or abolish any useful restriction site. We establish a GeneComb-based strategy to identify this mutation in a population of Sicilian unrelated clinically diagnosed FH probands. The method was very sensitive and specific; 12 out of 90 (13.3%) unrelated FH probands were found to carry the FH-Genoa/Palermo mutation. According to these results, the FH-Genoa/Palermo is the more frequent LDL-receptor gene mutation among the Sicilian FH patients. Moreover FH-Genoa/Palermo is the mutation cluster to date more represented in Southern Italy.


Subject(s)
Genetic Testing , Hyperlipoproteinemia Type II/genetics , Point Mutation , Receptors, LDL/genetics , Humans
17.
Exp Gerontol ; 34(1): 47-57, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10197727

ABSTRACT

Successful aging, characterized by little or no loss in physiological functions, should be the usual aging process in centenarians. It is known that well-preserved physiological functions depend on the proper functioning of cell systems. In this article we focus on cell membrane integrity and study the red blood cell membrane to evaluate the effect of physiological aging in centenarians. Fifteen healthy, self-sufficient centenarians, mean age 103 years, were examined by assessing hemocytometric values and some relevant characteristics of the erythrocyte membrane, i.e., the cholesterol/phospholipid molar ratio, the distribution of phospholipid classes and their fatty acid composition, the integral and skeletal protein profiles. The centenarians showed a significant decrease in the red blood cell count (p < 0.0002), hemoglobin (p < 0.0002), and hematocrit (p < 0.0005). The red blood cell membrane showed a significantly increased cholesterol/phospholipid molar ratio (p < 0.01), with a concomitant increase in polyunsaturated fatty acids in phosphatidylcholine (p < 0.001) and, to a lesser extent, in phosphatidylethanolamine. The electrophoretic pattern of membrane proteins was qualitatively normal compared to controls but the densitometric analysis showed a significant increase in the integral protein band 4.2 (p < 0.05) and in the skeletal protein actin (p < 0.001). Extreme longevity seems to be associated with a substantial integrity of the erythrocyte membrane. Moreover, the evident increase in polyunsaturated fatty acids and in actin are likely to improve the membrane fluidity and to strengthen the membrane structure.


Subject(s)
Aging/blood , Erythrocyte Membrane/chemistry , Aged , Aged, 80 and over , Female , Humans , Longevity , Male , Membrane Lipids/blood , Membrane Proteins/blood
18.
Biochim Biophys Acta ; 1437(3): 367-77, 1999 Mar 25.
Article in English | MEDLINE | ID: mdl-10101270

ABSTRACT

Both estrogen and dietary n-3 polyunsaturated fatty acids are known to be hypocholesterolemic, but appear to exert their effects by different mechanisms. In this study, the interaction between dietary fish oil (rich in n-3 polyunsaturated fatty acids) and estrogen in the regulation of hepatic cholesterol metabolism and biliary lipid secretion in rats was studied. Rats fed a low fat or a fish oil-supplemented diet for 21 days were injected with 17alpha-ethinyl estradiol (5 mg/kg body weight) or the vehicle only (control rats) once per day for 3 consecutive days. Estrogen-treatment led to a marked reduction in plasma cholesterol levels in fish oil-fed rats, which was greater than that observed with either estrogen or dietary fish oil alone. The expression of mRNA for cholesterol 7alpha-hydroxylase was decreased by estrogen in rats fed a low fat or a fish oil-supplemented diet, while the output of cholesterol (micromol/h/kg b.wt.) in the bile was unchanged in both groups. Cholesterol levels in the liver were increased by estrogen in rats given either diet, but there was a significant shift from cholesterol esterification to cholesteryl ester hydrolysis only in the fish oil-fed animals. Estrogen increased the concentration of cholesterol (micromol/ml) in the bile in rats fed the fish oil, but not the low fat diet. However, the cholesterol saturation index was unaffected. The output and concentration of total bile acid was also unaffected, but changes in the distribution of the individual bile acids were observed with estrogen treatment in both low fat and fish oil-fed groups. These results show that interaction between estrogen-treatment and dietary n-3 polyunsaturated fatty acids causes changes in hepatic cholesterol metabolism and biliary lipid secretion in rats, but does not increase the excretion of cholesterol from the body.


Subject(s)
Bile/chemistry , Cholesterol/metabolism , Dietary Fats, Unsaturated/administration & dosage , Estrogens/pharmacology , Fish Oils/administration & dosage , Liver/metabolism , Animals , Bile/metabolism , Cholesterol/analysis , Cholesterol/blood , Cholesterol 7-alpha-Hydroxylase/genetics , Male , RNA, Messenger/biosynthesis , Rats , Rats, Wistar
19.
Proc Soc Exp Biol Med ; 220(1): 31-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9893166

ABSTRACT

The effects of cholesteryl ester transfer protein (CETP) on the direct uptake of HDL cholesteryl ester by the liver was investigated using the rat in vivo and the isolated perfused rat liver as experimental models. Rat plasma was incubated with [3H]cholesterol in the presence or absence of partially purified human CETP for 18 hr and [3H] cholesteryl ester-labeled HDL was then isolated by ultracentrifugation. The CETP-treated as compared to untreated HDL showed a small shift toward a lower density in the peak of lipoprotein cholesterol, suggesting that the HDL particle size was increased. After injection of the labeled HDL into rats in vivo, more radioactivity remained in the plasma after 60 min when the CETP-treated preparation was used, but the amounts found in the liver and secreted in the bile were not significantly different from those obtained with the untreated HDL. The distribution of the label remaining in the plasma after 60 min between different density fractions corresponding to HDL subclasses suggested that the uptake of HDL2 and HDL3 was delayed by CETP treatment. Radioactivity from CETP-treated HDL was also removed from the perfusate of isolated perfused rat livers more slowly than that from untreated HDL, and in this case the amount found in the liver after 60 min was significantly lower. These findings indicate that treatment with CETP has a direct inhibitory effect on the clearance of rat HDL cholesteryl ester from the blood and its uptake by the liver.


Subject(s)
Carrier Proteins/pharmacology , Cholesterol Esters/metabolism , Cholesterol, HDL/metabolism , Glycoproteins , Liver/drug effects , Animals , Carrier Proteins/isolation & purification , Carrier Proteins/metabolism , Centrifugation, Density Gradient , Cholesterol Ester Transfer Proteins , Cholesterol, HDL/chemistry , Humans , In Vitro Techniques , Liver/metabolism , Male , Perfusion , Rats , Rats, Wistar
20.
Ann Ist Super Sanita ; 35(2): 177-84, 1999.
Article in Italian | MEDLINE | ID: mdl-10645650

ABSTRACT

The review takes into account molecular bases and major implications for public health in our country of familial hypercholesterolemia (FH) caused by mutations in LDL receptor (LDLR) gene. The relevance of the problem is evidenced by the fact that (a) about 120,000 Italians affected by heterozygous FH face a cardiovascular risk much higher than normal individuals, and (b) their identification is difficult because of the plethora of mutations existing in the country. This report deepens also the relationships between alterations in the coding sequence of LDLR gene and in the function of LDLR protein. Furthermore, it describes, in terms of molecular characteristics and diffusion, the 42 mutations so far detected in Italy that cause about 30% of FH cases. This led us to hypothesize the existence in our country of over hundred different mutations present within defined geographical areas where, in a few cases, they may also have a relatively high incidence (i.e., the so-called FH-clusters). Finally, preliminary studies mentioned here point out the existence of significant correlations between phenotype and genotype of FH and suggest the possibility of realizing on a large scale an early diagnosis and therapy of pathologies caused by a function deficit in LDL receptor.


Subject(s)
Hyperlipoproteinemia Type II/genetics , Receptors, LDL/genetics , Heterozygote , Humans , Hyperlipoproteinemia Type II/epidemiology , Incidence , Italy/epidemiology , Mutation , Receptors, LDL/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...